Mindray (MR) (NEWP) (NTAP) (EA) (ENDP) (FRX) Ratings Reiterated

Mindray Medical International Limited (NYSE: MR), Newport Co. (NASDAQ: NEWP), NetApp Inc. (NASDAQ: NTAP), Electronic Arts Inc. (NYSE: EA), Endo Pharmaceuticals (NASDAQ: ENDP) and Forest Laboratories, Inc. (NYSE: FRX) had ratings on them reiterated by analysts.

Oppenheimer reiterated its "Outperform" rating on Mindray Medical International Limited (MR).

Needham & Company reiterated its "Buy" rating on Newport Co. (NEWP).

Piper Jaffray (NYSE:PJC) reiterated its "Overweight" rating on NetApp Inc. (NTAP). They have a price target of $53.00 on the company.

Bank of America (NYSE:BAC) reiterated its "Neutral" rating on Electronic Arts Inc. (EA). They have a price target of $28.00 on the company.

Citigroup (NYSE:C) reiterated its "Buy" rating on Endo Pharmaceuticals (ENDP). They have a price target of $48.00 on the company.

Citigroup reiterated its "Neutral" rating on Forest Laboratories, Inc. (FRX). They have a price target of $35.00 on the company.